Borisenko S A
Biull Eksp Biol Med. 1988 Dec;106(12):686-8.
Carbidopa at a dose 40 and 80 mg/kg, i.p. had no effect on BBB permeability for 14C-tyrosine but increased in a dose-dependent manner the penetration of 14C-DOPA into the brain. DMSO at a dose 1.75, 3.5 and 7 g/kg, i.p. increased the BBB permeability for both isotopes but to a greater extent for the labeled tyrosine. Carbidopa combined with DMSO produced more marked increase of BBB permeability for 14C-DOPA in comparison to their separate application and had no effect on 14C-tyrosine penetration. It is suggested that the increased passage of DOPA through the BBB can be achieved by weakening of the enzymatic component of the BBB as well as by the activation of unspecific transport mechanisms (pinocytosis) of the BBB.
腹腔注射剂量为40和80毫克/千克的卡比多巴对血脑屏障对14C-酪氨酸的通透性没有影响,但14C-多巴进入脑内的渗透率却呈剂量依赖性增加。腹腔注射剂量为1.75、3.5和7克/千克的二甲基亚砜增加了两种同位素的血脑屏障通透性,但对标记酪氨酸的增加幅度更大。与单独应用相比,卡比多巴与二甲基亚砜联合应用使血脑屏障对14C-多巴的通透性增加更为显著,且对14C-酪氨酸的渗透没有影响。有人认为,多巴通过血脑屏障的增加可通过削弱血脑屏障的酶成分以及激活血脑屏障的非特异性转运机制(胞饮作用)来实现。